OneAlphaMed built an always-on, multi-channel precision content engine that replaced brand-heavy promotional emails with highly anticipated clinical infographics — achieving a sustained 25%+ open rate at scale.
Industry / Specialty
Pharmaceutical & Healthcare
Scale / Audience
15,000+ HCPs
Core Solutions
Co-created Certification
Time to Value
Pan-India Deployment
Stop funding clicks. Start building undisputed credibility for your brand today.
A leading cardiovascular brand was suffering from chronically plummeting open rates on its digital communications. After years of one-size-fits-all promotional campaigns, their cardiologist audience had developed strong habits of ignoring or deleting their emails. OneAlphaMed architected a ‘Precision Content Engine’ that systematized the creation of high-value, highly visual clinical infographics and dynamically routed them via WhatsApp and Email to precisely segmented cardiology sub-specialties. Within 90 days, the brand transformed from a promoter into a credible, trusted scientific partner — achieving a sustained 25%+ open rate across an audience of 40,000+ HCPs.
A decade of promotional email campaigns had left the brand's audience deeply fatigued, actively filtering out their communications before even reading the subject line.
Cardiologists — bombarded daily by pharmaceutical marketing emails from dozens of companies — had developed strong, automated habits of ignoring or immediately deleting any content that appeared promotional. The brand's email domain had been mentally 'spam-classified' by a significant portion of its target audience, making conventional digital reactivation strategies ineffective.
The brand's inconsistent, text-heavy messaging failed to build meaningful recall. In blinded surveys, a significant proportion of the target cardiologist audience could not accurately recall the brand's key scientific claims after 30 days — indicating that even communications that were opened were failing to create a lasting intellectual impression.
The cardiology landscape is highly fragmented. Electrophysiologists, interventional cardiologists, heart failure specialists, and preventive cardiologists have fundamentally different clinical priorities and informational needs. Sending identical scientific messaging to this entire group consistently resulted in content that felt irrelevant to the majority of its recipients.
OneAlphaMed replaced one-off, campaign-led communications with a systematized, always-on content factory — engineered for precision, not volume.
OneAlphaMed established a dedicated medical writing and design team tasked with systematically producing a continuous stream of high-fidelity clinical infographics. Each asset focused on a single, actionable clinical insight — drawn from recent trial data, guideline updates, or clinically-relevant case scenarios — and was designed to be consumed completely in under 90 seconds.
OneAlphaMed implemented a dynamic content routing system driven by HCP specialty classification data. Electrophysiologists received infographics on arrhythmia management and ablation evidence; interventional cardiologists received percutaneous intervention data; heart failure specialists received guideline update summaries. Each HCP received content that was immediately clinically relevant to their daily practice.
To break through email fatigue, OneAlphaMed deployed a dual-channel delivery strategy. Formal, detailed infographics were sent via email for archiving and reference; brief, visually bold '30-second insight' versions of the same content were simultaneously pushed via WhatsApp, meeting cardiologists where they already communicate and dramatically improving initial read rates.
Breaking the One-Off Campaign Cycle.
The fundamental innovation was architectural, not tactical. By creating a systematic content engine rather than executing isolated monthly campaigns, OneAlphaMed transformed what had been a fragmented brand communications calendar into a cohesive, always-on scientific presence. The brand stopped being a company that ran campaigns and became a channel that cardiologists actively chose to follow.
The precision engine proved its value rapidly, replacing vanity click metrics with genuine, measurable scientific engagement.
The content engine did more than deliver messages; it structurally and permanently changed the brand's position in the minds of its most important audience.
Experienced a complete transformation of their digital relationship with the brand — from spam-filtering promotional emails to actively anticipating and sharing carefully curated, directly relevant clinical updates. In follow-up surveys, cardiologists consistently cited the brand's content as among the most useful and scientifically credible pharmaceutical communications they regularly received.
Created a sustainable, scalable content pipeline with standardized quality controls, eliminating the stressful, low-quality monthly scramble for campaign materials. The systematized approach also generated a growing content library that could be repurposed for MSL leave-behind tools, medical congress materials, and sales aid supplements.
Achieved a measurable, documented perception shift from promoter to partner. The brand's 'top-of-mind awareness' scores among cardiologists increased significantly within two quarters — a strategic asset that directly supports sales force effectiveness and long-term prescription behavior.
WhatsApp has emerged as the primary professional communication tool for physicians across South Asia, Southeast Asia, the Middle East, and increasingly Europe. For pharmaceutical brands, it offers the ability to cut through a severely over-crowded email inbox and meet doctors in a communication environment they actively monitor throughout their clinical day. Our approach uses broadcast-only, opt-in registered business accounts fully compliant with WhatsApp Business API policies and local pharmaceutical marketing regulations.
We utilize a dedicated medical writing team with therapeutic area specialization, paired with a standardized multi-step scientific review workflow. Every asset goes through medical, regulatory, and legal clearance before deployment, and we maintain a master content library with version-controlled citation tracking for every clinical claim.
Absolutely. The engine's underlying architecture — specialty segmentation data, content routing logic, and multi-channel delivery infrastructure — is therapy-agnostic. We have successfully deployed similar engines in Diabetology, Respiratory Medicine, and Neurology, with the core technology transferring directly and requiring only therapeutic area-specific content calibration.
+91 9811660635
info@onealphamed.com
2414, Ground Floor, Aravali Vihar, Sector 49 Faridabad, Haryana – 121001 India
Copyright © 2026 OneAlphaMed. All Rights Reserved.